Alcohol Use Disorder Clinical Trials
106 studies are recruiting for alcohol use disorder in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies, page 4
-
A Randomized Controlled Trial of Digital CBT to Treat Addiction: Digital RITch®CBT vs. Standard CBT
Substance Use Disorders continue to increase across the United States with significant adverse effects resulting in more than $700 billion annually (NIDA, 2017) with high co-occurring rates of IPV. The negative consequences are devastating to families and society. This team has developed a digital,…
- Stage
- Not phased
- Ages
- 18 to 65
- Site
- Strong Recovery - Part Of Strong Memorial Hospital, Rochester, New York
- Run by
- University of Rochester
-
Naltrexone in AUD Reward Drinkers
This study is a phase IV, two-arm, randomized, double-blind, placebo-controlled study to assess whether individuals identified as primarily reward drinkers are significantly more likely to reduce heavy drinking if they receive XR-NTX than a matching placebo injection. Study subjects will receive mo…
- Stage
- Phase 4
- Ages
- 18 to 65
- Site
- University of Pennsylvania Center for Studies of Addiction, Philadelphia, Pennsylvania
- Run by
- University of Pennsylvania
-
Acute Alcohol Response In Bipolar Disorder: a Longitudinal Alcohol Administration/fMRI Study
Alcohol use disorders (AUDs) affect up to 60% of individuals with bipolar disorder during their lifetime and is associated with worse illness outcomes, yet few studies have been performed to clarify the causes of this comorbidity. Understanding biological risk factors that associate with and predic…
- Stage
- Not phased
- Ages
- 21 to 26
- Site
- University of Texas at Austin, Austin, Texas
- Run by
- University of Texas at Austin
-
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
This project is designed to determine if a computer-delivered cognitive-behavioral treatment can improve the otherwise poor alcohol use disorder treatment outcomes for individuals with a co-occurring anxiety disorder. In the past, the investigators showed that this treatment does improve outcomes f…
- Stage
- Not phased
- Ages
- 18 to 65
- Site
- Lodging Plus Program, Fairview Hospital, Minneapolis, Minnesota
- Run by
- University of Minnesota
-
Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking
The goal of this clinical trial is to learn if, how, and for whom suvorexant (SUV) works to treat alcohol use disorder (AUD). The main questions it aims to answer are: * Is SUV effective for AUD? * Does SUV dampen stress reactivity? * Can the researchers develop a biomarker for SUV treatment respon…
- Stage
- Phase 2
- Ages
- 18 to 65
- Site
- Ohio State University, Columbus, Ohio
- Run by
- Ohio State University
-
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
This study will collect data that measures the effects of a psychedelic intervention on patients struggling with alcohol use disorder (AUD). The study design will be a double blind, randomized, active-comparator trial with two study arms. Subjects randomized to Arm 1 (n=40) will receive individual …
- Stage
- Phase 2
- Ages
- 21 to 65
- Site
- University of Iowa Health Care, Iowa City, Iowa
- Run by
- University of Iowa
-
LGG Supplementation in Patients With AUD and ALD
To test the efficacy of 6-month LGG compared to placebo in treating Alcoholic Use Disorder (AUD) and liver injury in Alcoholic Hepatitis (AH). And to evaluate the effects of LGG treatment compared to placebo on therapeutic-mechanistic markers of the gut-brain axis and pro-inflammatory activity in p…
- Stage
- Phase 2
- Ages
- 21 to 65
- Site
- University of Louisville Hospital, Louisville, Kentucky
- Run by
- University of Louisville
-
Tirzepatide for Alcohol Use Disorder
The objective of this Phase 2 randomized controlled trial is to evaluate the effects of weekly tirzepatide (vs. placebo) on alcohol consumption and cardiometabolic outcomes in adults with alcohol use disorder and overweight or obesity.
- Stage
- Phase 2
- Ages
- 21 to 65
- Site
- Keck School of Medicine, University of Southern California, Los Angeles, California
- Run by
- University of Southern California
-
Tdcs And cogNitive traininG cOmbined for AUD (TANGO)
The overarching goal of this project is to expand the traditional expertise in non-invasive neuromodulation at the University of Minnesota towards developing novel paired-neuromodulation approaches using transcranial direct current stimulation (tDCS) for new treatments for alcohol use disorder (AUD…
- Stage
- Not phased
- Ages
- 18 to 65
- Site
- University of Minnesota, Minneapolis, Minnesota
- Run by
- University of Minnesota
-
A Combined Neurofeedback-TMS Intervention for Alcohol Use Disorder
The goal of this clinical study is to test the effectiveness of a supplemental fMRI neurofeedback and/or TMS intervention in individuals seeking treatment for Alcohol Use Disorder. After an initial visit, participants will come in once a week for four (4) weeks for an intervention session, which ma…
- Stage
- Not phased
- Ages
- 19 to 65
- Site
- Auburn University, Auburn, Alabama
- Run by
- Auburn University
-
Emergency Medicine Peer Outreach Worker Engagement for Recovery
This is an observational, prospective case-control study evaluating the effects of an emergency department community health worker-peer recovery specialist program (PCHW), the Substance Misuse Assistance Response Team (SMART). Aims of this study are to 1) understand participant experiences working …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Rhode Island Hospital, Providence, Rhode Island
- Run by
- University of California, Los Angeles
-
Effects of Ketone Supplementation on Alcohol Withdrawal and Brain Metabolism in Alcohol Use Disorder
The goal of this clinical trial is to learn the effects of ketone supplement compared to placebo on alcohol withdrawal symptoms during a 4 day alcohol withdrawal management treatment in adults with moderate to severe alcohol use disorder at the Hospital of the University of Pennsylvania, Cedar Deto…
- Stage
- Phase 2
- Ages
- 18 to 65
- Site
- Center for Studies of Addiction, Philadelphia, Pennsylvania
- Run by
- University of Pennsylvania
-
Intranasal Insulin for Treatment of Alcohol Use Disorder
This is a randomized controlled trial (RCT), within-subject, crossover, double-blind, placebo-controlled in non-treatment-seeking individuals with Alcohol Use Disorder (AUD) (N=40, 50% female) randomized to IN insulin or placebo. In a bar laboratory setting, randomized participants will receive a s…
- Stage
- Phase 1
- Ages
- 21 and older
- Site
- Brown University, Providence, Rhode Island
- Run by
- Brown University
-
A Peer Recovery Coaching Intervention for Hospitalized Alcohol Use Disorder Patients
The project objective is to rigorously evaluate the effectiveness of a peer recovery coaching intervention (called RC-Link) in patients hospitalized with medical complications from alcohol use on recovery outcomes guided by the new NIAAA definition of recovery, examine mechanisms of heavy drinking …
- Stage
- Not phased
- Ages
- 18 to 75
- Site
- Greenville Memorial Hospital, Greenville, South Carolina
- Locations
- 2 in total
- Run by
- Clemson University
-
Trial of a Culturally Informed Brief Intervention to Reduce Alcohol Related Health Disparities and Treatment Inequities Among Latinxs
This Stage II Randomized Efficacy Trial will compare the effectiveness of a theoretically informed and culturally responsive brief motivational intervention to a non-adapted brief intervention among non-treatment seeking Latinxs admitted for medical treatment of an injury who engage in at risk drin…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University Medical Center of El Paso, El Paso, Texas
- Run by
- University of Texas, El Paso
-
Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder
Alcohol Use Disorders are currently positioned as the third leading cause of preventable death in the United States, constituting a humanitarian crisis with substantial financial burden on society and medical facilities. While several pharmacological interventions exist, 60% of individuals who seek…
- Stage
- Not phased
- Ages
- 25 to 75
- Site
- VA Palo Alto Health Care System, Palo Alto, California
- Run by
- VA Palo Alto Health Care System
-
Amplification of Positivity for Alcohol Use
The proposed study consists of two phases. During Phase 1, the investigators will recruit a small sample of participants to complete a psychosocial intervention termed Amplification of Positivity (AMP) for individuals experiencing comorbid depression or anxiety disorders and alcohol use disorder (A…
- Stage
- Not phased
- Ages
- 18 to 65
- Site
- Laureate Institute for Brain Research, Tulsa, Oklahoma
- Run by
- Laureate Institute for Brain Research, Inc.
-
Electronic Harm Reduction Treatment for Alcohol
The goal of this project is to transform a successful, face-to-face harm-reduction treatment (HaRT-A) into a digital format, creating eHaRT-A. This new platform is specifically designed for people who have experienced homelessness and an alcohol use disorder (AUD), living within the framework of pe…
- Stage
- Phase 3
- Ages
- 21 and older
- Site
- Downtown Emergency Service Center, Seattle, Washington
- Run by
- University of Washington
-
Evaluating a One-Year Version of the Parent-Child Assistance Program
The proposed project seeks to achieve three objectives that will, collectively, evaluate the effectiveness of a one-year version of the Parent-Child Assistance Program (PCAP-1) -a model for a home visitation and case management program for parents who used substances. First, the proposed project ai…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Remote Worker, Enid, Oklahoma
- Locations
- 2 in total
- Run by
- University of Oklahoma
-
rTMS as Add on Treatment for Substance Use Disorders
This pilot study is designed to test feasibility and superiority of rTMS types and target locations for the optimal rTMS intervention for individuals seeking treatment for Alcohol Use Disorder (AUD) or Opioid Use Disorder (OUD). The critical questions this study seeks to answer are: which rTMS type…
- Stage
- Not phased
- Ages
- 18 to 60
- Site
- Hartford Healthcare, Hartford, Connecticut
- Run by
- Yale University
-
Virtual Incentive Treatment for Alcohol
The overall objective of this program of research is to utilize phosphatidylethanol (PEth), a blood-based biomarker that can detect alcohol use for up to 28 days to deliver a feasible telehealth-based 26-week CM intervention. This study will test a telehealth PEth-based CM model in a sample of adul…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Washington State University, Spokane, Washington
- Run by
- Washington State University
-
A Pilot Study of Non-invasive Brain Stimulation to Boost the Efficacy of Psychotherapy in a Community Sample of People Who Drink Alcohol
The goal of this small (n=75) proof-of-concept randomized clinical trial is to test the effects of transcranial alternating current stimulation (tACS) during motivational interviewing (MI) sessions with participants who drink at above the low-risk level. Participants will be randomized to receive e…
- Stage
- Phase 2
- Ages
- 21 to 60
- Site
- The Mind Research Network, Albuquerque, New Mexico
- Run by
- The Mind Research Network
-
Systematic Implementation of Patient-centered Care for Alcohol Use Trial: Beyond Referral to Treatment
The Systematic Implementation of Patient-centered Care for Alcohol Use Trial is a pragmatic, cluster-randomized, effectiveness-implementation trial testing two interventions in Kaiser Permanente Washington to systematically implement shared decision-making with primary care patients with symptoms d…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Kaiser Permanente Washington, Seattle, Washington
- Run by
- Kaiser Permanente
-
Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD
This is a double-blind, 2-group randomized controlled trial evaluating the effects of topiramate versus placebo in patients with comorbid PTSD and moderate-to-severe AUD. This trial will provide one of the first rigorous tests of whether the effects of topiramate in AUD generalize to patients with …
- Stage
- Phase 2
- Ages
- 18 to 70
- Site
- New York University School of Medicine, New York, New York
- Run by
- NYU Langone Health
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
Ecological momentary interventions (EMI), which use phones to deliver messages to reduce alcohol use and related risk behaviors during or prior to drinking events, can help to address triggers in real-time. GPS tracking can determine when individuals visit places they have previously reported drink…
- Stage
- Not phased
- Ages
- 18 to 35
- Site
- Yale University, New Haven, Connecticut
- Locations
- 2 in total
- Run by
- University of Kentucky
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.